Oregon 2023 Regular Session

Oregon House Bill HB2395

Introduced
1/9/23  
Refer
1/11/23  
Report Pass
2/27/23  
Engrossed
3/7/23  
Refer
3/8/23  
Report Pass
6/15/23  
Enrolled
6/15/23  
Report Pass
6/21/23  
Enrolled
6/24/23  
Passed
8/4/23  
Chaptered
8/21/23  

Caption

Relating to substance use; and declaring an emergency.

Impact

The enactment of HB 2395 is expected to have a significant effect on state laws relating to substance use and public health. It creates provisions for civil and criminal immunity for individuals administering opioid antagonists in good faith, thereby encouraging more people to respond to overdoses without fear of legal repercussions. Additionally, the bill stipulates that minors can access outpatient substance use treatment without parental consent, promoting greater accessibility for at-risk youth. This aspect addresses concerns about stigma and barriers to care for younger populations struggling with substance use disorders.

Summary

House Bill 2395 aims to address the ongoing opioid crisis in Oregon through comprehensive measures focused on substance use prevention, harm reduction, and treatment. The bill mandates the Oregon Health Authority to conduct a study on substance use and submit findings to legislative committees by mid-2024. In addition, it allows specified individuals to distribute and administer short-acting opioid antagonists, such as naloxone, and establishes provisions for pharmacies and social service agencies to provide these life-saving kits to individuals likely to experience an overdose. The bill emphasizes the importance of immediate action to combat unnecessary loss of life due to opioid overdoses.

Contention

Discussions surrounding HB 2395 highlighted some contention, particularly regarding the balance between public health initiatives and individual rights. Supporters argue that the bill crucially aligns with Oregon's need for a multi-faceted approach to the opioid crisis, while critics fear that the provisions for minors receiving treatment without parental consent might undermine parental authority. Furthermore, there are ongoing debates about the adequacy of funding and resources that will be required to implement the proposed strategies effectively. The overall sentiment among proponents is that the bill offers a life-saving approach, while opponents stress the need for careful consideration of its impacts on family dynamics.

Companion Bills

No companion bills found.

Similar Bills

OR HB2887

Relating to short-acting opioid antagonists; prescribing an effective date.

OR SB12

Relating to opioid antagonists.

OR HB2884

Relating to short-acting opioid antagonists.

MS HB1137

Opioid antagonists; authorize community organizations and others to receive and administer.

CT HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

KS HB2390

House Substitute for HB 2390 by Committee on Public Health and Welfare - Requiring the secretary of health and environment to study drug overdose death cases and providing for the confidentiality of acquired and related records, restricting the authority of the secretary of health and environment and local health officers to prevent the introduction and spread of infectious or contagious diseases and repealing the authority of the secretary to quarantine individuals and impose associated penalties.

VA HB1511

Midwifery; administration of medication.

VA HB2497

Midwifery; administration of medication within scope of practice.